In a filing, Johnson & Johnson revealed its Officer Decker Robert J acquired Company’s shares for reported $1.16 million on Feb 25 ’25. In the deal valued at $165.88 per share,6,999 shares were bought.
Then, Schmid Timothy sold 403 shares, generating $62,928 in total proceeds. Upon selling the shares at $156.15, the EVP, WW Chair, MedTech now owns 15,098 shares.
Before that, Wolk Joseph J sold 13,015 shares. Johnson & Johnson shares valued at $2,002,878 were divested by the Exec VP, CFO at a price of $153.89 per share. As a result of the transaction, Wolk Joseph J now holds 0 shares, worth roughly $0.0.
A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. Daiwa Securities also remained covering JNJ and has decreased its forecast on July 23, 2024 with a “Neutral” recommendation from previously “an Outperform” rating.
Price Performance Review of JNJ
On Tuesday, Johnson & Johnson [NYSE:JNJ] saw its stock jump 1.44% to $166.09. Over the last five days, the stock has gained 7.16%. Johnson & Johnson shares have risen nearly 14.85% since the year began. Nevertheless, the stocks have risen 3.52% over the past one year. While a 52-week high of $168.85 was reached on 02/25/25, a 52-week low of $140.68 was recorded on 01/10/25. SMA at 50 days reached $149.61, while 200 days put it at $154.49.
Levels Of Support And Resistance For JNJ Stock
The 24-hour chart illustrates a support level at 164.54, which if violated will result in even more drops to 163.00. On the upside, there is a resistance level at 167.03. A further resistance level may holdings at 167.98. The Relative Strength Index (RSI) on the 14-day chart is 76.16, which indicates overbought technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 6.54, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 2.40%. Stochastics %K at 93.33% indicates the stock is a selling.